Carregant...
Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors
BACKGROUND: Motesanib is a potent inhibitor of VEGFR1, 2 and 3, PDGFR and Kit receptors. In this report we examine the interaction between motesanib and radiation in vitro and in head and neck squamous cell carcinoma (HNSCC) xenograft models. EXPERIMENTAL DESIGN: In vitro assays were performed to as...
Guardat en:
Autors principals: | , , , , , , , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
2010
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3216115/ https://ncbi.nlm.nih.gov/pubmed/20507929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-3385 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|